two new therapies for advanced breast cancer

Zeneca will be promoting two new therapies for advanced breast cancer...Zoladex (goserelin implant) and Arimidex (anastrozole).

Zoladex is already on the market for treating prostate cancer and endometriosis.

Now it's also approved for metastatic breast women who have NOT yet gone through menopause.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote